Your browser doesn't support javascript.
loading
Safety and efficacy of nivolumab plus ipilimumab in patients with advanced renal cell carcinoma with brain metastases: CheckMate 920.
Emamekhoo, Hamid; Olsen, Mark R; Carthon, Bradley C; Drakaki, Alexandra; Percent, Ivor J; Molina, Ana M; Cho, Daniel C; Bendell, Johanna C; Gordan, Lucio N; Rezazadeh Kalebasty, Arash; George, Daniel J; Hutson, Thomas E; Arrowsmith, Edward R; Zhang, Joshua; Zoco, Jesus; Johansen, Jennifer L; Leung, David K; Tykodi, Scott S.
Afiliação
  • Emamekhoo H; University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin.
  • Olsen MR; Oklahoma Cancer Specialists and Research Institute, Tulsa, Oklahoma.
  • Carthon BC; Department of Hematology and Medical Oncology, Emory University Hospital Midtown, Atlanta, Georgia.
  • Drakaki A; Division of Hematology/Oncology, Institute of Urologic Oncology, UCLA Health, Los Angeles, California.
  • Percent IJ; Florida Cancer Specialists, Port Charlotte, Florida.
  • Molina AM; Weill Cornell Medicine, New York, New York.
  • Cho DC; Perlmutter Cancer Center at New York University Langone Medical Center, New York, New York.
  • Bendell JC; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, Tennessee.
  • Gordan LN; Florida Cancer Specialists North/Sarah Cannon Research Institute, Gainesville, Florida.
  • Rezazadeh Kalebasty A; Norton Cancer Institute, Louisville, Kentucky.
  • George DJ; Duke University Medical Center, Durham, North Carolina.
  • Hutson TE; Texas A&M College of Medicine, Bryan, Texas.
  • Arrowsmith ER; Sarah Cannon Research Institute/Tennessee Oncology, Chattanooga, Tennessee.
  • Zhang J; Bristol Myers Squibb, Princeton, New Jersey.
  • Zoco J; Syneos Health, Braine l'Alleud, Belgium.
  • Johansen JL; Bristol Myers Squibb, Princeton, New Jersey.
  • Leung DK; Bristol Myers Squibb, Princeton, New Jersey.
  • Tykodi SS; University of Washington and Fred Hutchinson Cancer Research Center, Seattle, Washington.
Cancer ; 128(5): 966-974, 2022 03 01.
Article em En | MEDLINE | ID: mdl-34784056

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Carcinoma de Células Renais / Protocolos de Quimioterapia Combinada Antineoplásica / Neoplasias Renais Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Ano de publicação: 2022 Tipo de documento: Article País de publicação: Estados Unidos